VTRS | tickerfilter.com

Fundamental analysis

37%

Profitability 38%

Dept financing 43%

Liquidity 58%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.74%

1 Month

-5.28%

3 Months

-27.18%

6 Months

-29.73%

1 Year

-29.97%

2 Year

-11.86%

Key data

Stock price

$8.25

P/E Ratio

0.00

DAY RANGE

$8.12 - $8.35

EPS

-$0.71

52 WEEK RANGE

$6.85 - $13.55

52 WEEK CHANGE

-$28.69

MARKET CAP

14.860 B

YIELD

3.86%

SHARES OUTSTANDING

1.194 B

DIVIDEND

$0.12

EX-DIVIDEND DATE

03-10-2025

NEXT EARNINGS DATE

05-08-2025

BETA

0.58

PUBLIC FLOAT

AVERAGE 10 VOLUME

$10,505,453

AVERAGE 30 VOLUME

$13,607,875

Company detail

CEO: Michael Goettler
Region: US
Website: viatris.com
Employees: 37,000
IPO year: 1987

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Viatris Inc. operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

VTRS - Viatris Inc